These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 420348)

  • 21. [Naloxone and naltrexone antagonism of various central effects of morphine].
    Piccinelli D; de Feo G; Mazzanti G
    Boll Soc Ital Biol Sper; 1986 Oct; 62(10):1213-20. PubMed ID: 3828119
    [No Abstract]   [Full Text] [Related]  

  • 22. Endogenous opiates and stress. Behavioral activation elicited in the rat and effects of naltrexone, diprenorphine and morphine.
    Katz RJ; Manik CP
    Neuropharmacology; 1984 Dec; 23(12A):1425-30. PubMed ID: 6543246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonidine hydrochloride detoxification from methadone treatments: the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    NIDA Res Monogr; 1981 Feb; 34():101-8. PubMed ID: 6783916
    [No Abstract]   [Full Text] [Related]  

  • 24. Naltrexone-induced hypothermia in the rat.
    Ary M; Chesarek W; Sorensen SM; Lomax P
    Eur J Pharmacol; 1976 Oct; 39(2):215-20. PubMed ID: 185061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment.
    Tempel A; Zukin RS; Gardner EL
    Life Sci; 1982 Sep 20-27; 31(12-13):1401-4. PubMed ID: 6292636
    [No Abstract]   [Full Text] [Related]  

  • 26. Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog.
    Pace NL; Wong KC
    Anesth Analg; 1979; 58(1):36-9. PubMed ID: 219728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Core temperature changes following administration of naloxone and naltrexone to rats exposed to hot and cold ambient temperatures. Evidence for the physiological role of endorphins in hot and cold acclimatization.
    Thornhill JA; Cooper KE; Veale WL
    J Pharm Pharmacol; 1980 Jun; 32(6):427-30. PubMed ID: 6106678
    [No Abstract]   [Full Text] [Related]  

  • 28. Naltrexone: a clinical perspective.
    Greenstein RA; Arndt IC; McLellan AT; O'Brien CP; Evans B
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):25-8. PubMed ID: 6469933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA; Resnick RB; Resnick E
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    Adv Alcohol Subst Abuse; 1984; 3(3):41-9. PubMed ID: 6093484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychiatric implications of endorphin research.
    Mackay AV
    Br J Psychiatry; 1979 Nov; 135():470-3. PubMed ID: 231991
    [No Abstract]   [Full Text] [Related]  

  • 33. Failure of beta-endorphin antiserum, naloxone, and naltrexone to alter physiologic growth hormone and insulin secretion.
    Tannenbaum GS; Panerai AE; Friesen HG
    Life Sci; 1979 Dec; 25(23):1983-90. PubMed ID: 393928
    [No Abstract]   [Full Text] [Related]  

  • 34. Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone.
    Verebey K; Mulé SJ
    NIDA Res Monogr; 1979; 27():296-301. PubMed ID: 121346
    [No Abstract]   [Full Text] [Related]  

  • 35. Methadone-induced endorphin dysfunction in addicts.
    Gold MS; Pottash AC; Extein I; Martin D; Kleber HD
    NIDA Res Monogr; 1982 Apr; 41():476-82. PubMed ID: 6289119
    [No Abstract]   [Full Text] [Related]  

  • 36. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates.
    Loimer N; Lenz K; Schmid R; Presslich O
    Am J Psychiatry; 1991 Jul; 148(7):933-5. PubMed ID: 2053636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An oral opiate antagonist in chronic schizophrenia: a pilot study.
    Mielke DH; Gallant DM
    Am J Psychiatry; 1977 Dec; 134(12):1430-1. PubMed ID: 920847
    [No Abstract]   [Full Text] [Related]  

  • 38. Naltrexone in chronic schizophrenia. Results of a clinical trial.
    Ragheb M; Berney S; Ban T
    Int Pharmacopsychiatry; 1980; 15(1):1-5. PubMed ID: 6993401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone antagonism of exploration in the rat.
    Katz RJ
    Int J Neurosci; 1979; 9(1):49-51. PubMed ID: 437945
    [No Abstract]   [Full Text] [Related]  

  • 40. [Narcotic withdrawal syndrome. Therapeutic methods].
    Cerdeño Impuesto V
    Rev Clin Esp; 1982 Oct; 167(1):65-9. PubMed ID: 6129686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.